D352 + D794

**D352 + D794** is an investigational combination of two compounds, D352 and D794, studied together primarily for their potential pharmacokinetic interactions and safety profile. No publicly available data describes their individual chemical identities, mechanisms, or therapeutic intentions. There is a clinical study evaluating drug-drug interaction and safety following co-administration in healthy adult volunteers, suggesting early-phase exploration, not targeting specific diseases directly[1][2]. The study does not mention treatment of any explicit condition, but associated registry entries indicate relevance to dyslipidemia (abnormal blood lipid levels), likely as part of exploratory or preliminary safety/pharmacology work[2][5]. Mechanism of action, active ingredients, and other key pharmacological details are not disclosed in published materials.